IPHA

Innate Pharma SA

Company with tickers: IPHA, IPHYF

CIK

1598599

CUSIP

45781K204

Shares Outstanding

93,719,323

Website

https://www.innate-pharma.com

Investor Relations

https://investors.innate-pharma.com/English/investors/overview/default.aspx

13F Activity (30d)

2 filings 1 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Upcoming events

Date	Event	Type
2026-09-17 00:00 UTC	Publication of half year financial statements	Event
2026-11-05 00:00 UTC	Publication of revenue and cash position for 3Q2026	Event

Recent news

Date	Headline
2026-05-22	Outcome of Innate Pharma’s 2026 Annual General Meeting
2026-05-19	Innate Pharma to participate in the Jefferies Global Healthcare Conference
2026-05-13	Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
2026-05-12	Number of Shares and Voting Rights of Innate Pharma as of May 12, 2026
2026-05-06	Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
2026-04-23	Innate Pharma to Participate in the D. Boral Capital Global Conference
2026-04-17	Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
2026-04-16	Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
2026-04-13	Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
2026-04-13	Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026

Past events

Date	Event	Type
2026-06-02	Jefferies Global Healthcare Conference	Conference
2026-05-21	Annual General Shareholders Meeting	Shareholder meeting
2026-05-13	Publication of revenue and cash position for 1Q2026	Event
2026-04-15	Kempen Life Sciences Conference	Conference
2026-03-26	Publication of 2025 financial statements	Event
2026-03-09	Leerink Partners Global Healthcare Conference 2026	Conference
2025-11-17	Jefferies Global Healthcare Conference	Conference
2025-11-13	Publication of revenue and cash position for 3Q2025	Event
2025-10-28	In-person & virtual event - Lacutamab: a Phase 3-ready asset	Event
2025-09-30	25th European Midcap Event	Event
2025-09-25	Individual shareholders meeting	Shareholder meeting
2025-09-17	Publication of half year financial statements	Event
2025-07-29	BTIG Virtual Biotechnology Conference	Conference
2025-06-26	Wolfe Research Virtual Biotech Day	Event
2025-06-24	H.C. Wainwright 3rd Annual Immune Cell Engager Virtual Conference	Conference
2025-06-09	Goldman Sachs 46th Annual Global Healthcare Conference	Conference
2025-06-03	Jefferies Global Healthcare Conference	Conference
2025-05-22	Annual General Shareholders Meeting	Shareholder meeting
2025-05-13	Publication of revenue and cash position for 1Q2025	Event
2025-04-24	AACR Oncology Industry Partnering Event	Event
2025-04-08	Stifel 2025 Virtual Targeted Oncology Forum	Event
2025-04-01	Life Sciences Van Lanschot Kempen Conference	Conference
2025-03-27	Publication of 2024 financial statements	Event
2025-03-11	Leerink's Global Healthcare Conference 2025	Conference
2025-02-05	The nectin-4 and ADC event	Event

Source: https://investors.innate-pharma.com/English/investors/overview/default.aspx